The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions-Reference-Cited by-同舟云学术

The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions

Published:2018-07 Issue:4 Volume:6 Page:1287-1296.e1
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Trubiano Jason A.,Strautins Kaija,Redwood Alec J.,Pavlos Rebecca,Konvinse Katherine C.,Aung Ar Kar,Slavin Monica A.,Thursky Karin A.,Grayson M. Lindsay,Phillips Elizabeth J.

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference43 articles.

1. A comparative analysis between antibiotic- and nonantibiotic-associated delayed cutaneous adverse drug reactions;Trubiano;J Allergy Clin Immunol Pract,2016

2. Severe cutaneous adverse reactions related to systemic antibiotics;Lin;Clin Infect Dis,2014

3. Phenotype standardization for immune-mediated drug-induced skin injury;Pirmohamed;Clin Pharmacol Ther,2011

4. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions;Barbaud;Br J Dermatol,2013

5. Reactivation of skin lesions after patch testing to investigate drug rash with eosinophilia and systemic symptoms (DRESS) syndrome;Cordoba;Actas Dermosifiliogr,2016

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delayed Skin Testing for Systemic Medications: Helpful or Not?;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

2. Non-IgE-mediated drug-induced hypersensitivity reactions in pediatrics;Current Opinion in Pediatrics;2024-08-20

3. Cephalosporin Allergy: Updates on Diagnostic Testing;Current Allergy and Asthma Reports;2024-08-14

4. In‐vivo and ex‐vivo tests for culprit drugs identification in severe cutaneous adverse drugs reactions;The Journal of Dermatology;2024-04-11

5. Integrating in vivo and ex vivo approaches for culprit drug identification in cutaneous adverse drug reactions from non‐beta lactam antibiotics;Experimental Dermatology;2024-04